Publications by authors named "Alessandra Siegmann"

Claim this Profile
U
Undetectable PSA predicts outcome after salvage radiotherapy for biochemical recurrence following radical prostatectomy.
Sophia Scharl, Luca Gartner, Dirk Heinz Gerhard Böhmer, Alessandra Siegmann, Reinhard Thamm

Radiother Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Dose Escalation on the Efficacy of Salvage Radiotherapy for Recurrent Prostate Cancer-A Risk-Adjusted, Matched-Pair Analysis.
Dirk Böhmer, Alessandra Siegmann, Sophia Scharl, Christian Ruf, Thomas Wiegel

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage Radiotherapy versus Observation for Biochemical Recurrence following Radical Prostatectomy for Prostate Cancer: A Matched Pair Analysis.
Derya Tilki, Felix Preisser, Reinhard Thamm, Raisa S Pompe, Felix K-H Chun, Alessandra Siegmann

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead-time bias does not falsify the efficacy of early salvage radiotherapy for recurrent prostate cancer.
Detlef Bartkowiak, Reinhard Thamm, Alessandra Siegmann, Dirk Böhmer, Volker Budach

Radiother Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of prostate-specific antigen persistence after radical prostatectomy on the efficacy of salvage radiotherapy in patients with primary N0 prostate cancer.
Detlef Bartkowiak, Alessandra Siegmann, Dirk Böhmer, Volker Budach, Thomas Wiegel

BJU Int· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of early salvage radiotherapy at PSA < 0.5 ng/ml and impact of post-SRT PSA nadir in post-prostatectomy recurrent prostate cancer.
Dirk Bottke, Detlef Bartkowiak, Alessandra Siegmann, Reinhard Thamm, Dirk Böhmer

Prostate Cancer Prostatic Dis· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival.
Detlef Bartkowiak, Reinhard Thamm, Dirk Bottke, Alessandra Siegmann, Dirk Böhmer

Acta Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining biochemical recurrence after radical prostatectomy and timing of early salvage radiotherapy : Informing the debate.
Lars Budäus, Jonas Schiffmann, Markus Graefen, Hartwig Huland, Pierre Tennstedt, Alessandra Siegmann

Strahlenther Onkol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PSA-response to salvage radiotherapy after radical prostatectomy correlates with freedom from progression and overall survival.
Detlef Bartkowiak, Dirk Bottke, Reinhard Thamm, Alessandra Siegmann, Wolfgang Hinkelbein

Radiother Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-specific antigen persistence after radical prostatectomy as a predictive factor of clinical relapse-free survival and overall survival: 10-year data of the ARO 96-02 trial.
Thomas Wiegel, Detlef Bartkowiak, Dirk Bottke, Reinhard Thamm, Axel Hinke, Alessandra Siegmann

Int J Radiat Oncol Biol Phys· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.
Thomas Wiegel, Detlef Bartkowiak, Dirk Bottke, Claudia Bronner, Ursula Steiner, Alessandra Siegmann

Eur Urol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 study of adjuvant radiotherapy versus wait and see in pT3 prostate cancer: impact of pathology review on analysis.
Dirk Bottke, Reinhard Golz, Stephan Störkel, Axel Hinke, Alessandra Siegmann

Eur Urol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage radiotherapy after prostatectomy - what is the best time to treat?
Alessandra Siegmann, Dirk Bottke, Julia Faehndrich, Maike Brachert, Gunnar Lohm

Radiother Oncol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study.
Alessandra Siegmann, Dirk Bottke, Julia Faehndrich, Gunnar Lohm, Kurt Miller

Strahlenther Onkol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.
Thomas Wiegel, Dirk Bottke, Ursula Steiner, Alessandra Siegmann, Reinhard Golz

J Clin Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
Thomas Wiegel, Gunnar Lohm, Dirk Bottke, Stefan Höcht, Kurt Miller, Alessandra Siegmann

Int J Radiat Oncol Biol Phys· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults.
Markus W Gross, Riglef Altscher, Michael Brandtner, Harald Haeusser-Mischlich, Ion C Chiricuta, Alessandra D Siegmann

Clin Neurol Neurosurg· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiochemotherapy in unresectable pancreatic cancer.
Stefan Höcht, Thomas Wiegel, Alessandra Siegmann, Wolfgang Hinkelbein

Front Radiat Ther Oncol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pelvic sidewall involvement in recurrent rectal cancer.
Stefan Höcht, Benno Mann, Christoph-Thomas Germer, Riad Hammad, Alessandra Siegmann

Int J Colorectal Dis· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent rectal cancer within the pelvis. A multicenter analysis of 123 patients and recommendations for adjuvant radiotherapy.
Stefan Höcht, Riad Hammad, Hans-Joachim Thiel, Thomas Wiegel, Alessandra Siegmann

Strahlenther Onkol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis